|
|
|
|
|
|
|
|
|
|
Hinweise |
|
|
Wiss. Komitee |
|
|
Adressen |
|
|
Presse |
|
|
Öffnungszeiten |
|
|
Gesellschaften |
|
|
Hotelreservierung |
|
|
Termine |
|
|
Rahmenprogramm |
|
|
Gebühren |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Online-Anmeldung
Online-Abstracts
Kontakt-Adressen
Congress Center Leipzig
zurück zum Start
Programm-Schwerpunkte-Gesellschaften
Symposium 10 Biologische und klinische Aspekte viral-hämorrhagischer Fieber |
||
17.00 - 18.30 |
Vorsitz Th. Grünewald; Leipzig, D. Teichmann; Berlin |
|
Level 1 – Raum 2 |
|
|
03.05.2001 |
Sy 10.01 |
Molekulare Targets für die Impfstoffentwicklung bei Filoviren |
17.00 |
St. Becker; Marburg |
|
Sy 10.02 |
T-Zell-vermittelte Immunität bei Arenavirus-Infektionen |
|
17.18 |
J. ter Meulen; Marburg |
|
Sy 10.03 |
Charakteristika und Therapie der Ebola-Virus-Infektion unter Endemie-Bedingungen |
|
17.36 |
Ch. Manegold, Ch. Drosten, H. Schmitz; Hamburg |
|
Sy 10.04 |
Therapie viral-hämorrhagischer Fieber unter Intensivbedingungen |
|
17.54 |
B. Köhler; Würzburg |
|
Sy 10.05 |
VHF Case Management im europäischen Vergleich |
|
18.12 |
M. Niedrig; Berlin |
|
|